Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep;28(9):3625-3637.
doi: 10.1038/s41380-023-02287-6. Epub 2023 Oct 16.

Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions

Affiliations
Review

Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions

Kenji Hashimoto. Mol Psychiatry. 2023 Sep.

Abstract

The human body harbors a diverse ecosystem of microorganisms, including bacteria, viruses, and fungi, collectively known as the microbiota. Current research is increasingly focusing on the potential association between the microbiota and various neuropsychiatric disorders. The microbiota resides in various parts of the body, such as the oral cavity, nasal passages, lungs, gut, skin, bladder, and vagina. The gut microbiota in the gastrointestinal tract has received particular attention due to its high abundance and its potential role in psychiatric and neurodegenerative disorders. However, the microbiota presents in other body tissues, though less abundant, also plays crucial role in immune system and human homeostasis, thus influencing the development and progression of neuropsychiatric disorders. For example, oral microbiota imbalance and associated periodontitis might increase the risk for neuropsychiatric disorders. Additionally, studies using the postmortem brain samples have detected the widespread presence of oral bacteria in the brains of patients with Alzheimer's disease. This article provides an overview of the emerging role of the host microbiota in neuropsychiatric disorders and discusses future directions, such as underlying biological mechanisms, reliable biomarkers associated with the host microbiota, and microbiota-targeted interventions, for research in this field.

PubMed Disclaimer

Conflict of interest statement

KH is the inventor of filed patent applications on “The use of R-Ketamine in the treatment of psychiatric diseases”, “(S)-norketamine and salt thereof as pharmaceutical”, “R-Ketamine and derivative thereof as prophylactic or therapeutic agent for neurodegeneration disease or recognition function disorder”, “Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases”, and “R-Ketamine and its derivatives as a preventive or therapeutic agent for a neurodevelopmental disorder” by the Chiba University. KH has also received speakers’ honoraria, consultant fee, or research support from Abbott, Boehringer-Ingelheim, Daiichi-Sankyo, Meiji Seika Pharma, Seikagaku Corporation, Dainippon-Sumitomo, Taisho, Otsuka, Murakami Farm and Perception Neuroscience.

Figures

Fig. 1
Fig. 1. Host microbiota in human body.
The human microbiota resides in the various tissues of the body, including the mouth, nose, gastrointestinal (GI) tract, lung, skin, bladder, and vagina. In the GI trats, the density of microbes in different locations, such as the stomach, duodenum, jejunum, ileum, and colon, has been shown [43]. Part of the figure was designed using resources from Biorender.com.
Fig. 2
Fig. 2. Potential interactions among the microbiota in the different organs.
The microbiota in one organ may potentially influence that in another organ. The gut microbiota, which constitutes the majority of the host’s microbiome, plays a central role in affecting health and disease throughout the body. Although there are proposed interactions between the microbiota of different organs, current evidence supporting these interactions remains limited. Dysbiosis in the microbiota across various different tissues may contribute to the incidence of organ-specific diseases. COPD: chronic obstructive pulmonary disease. Part of the figure was designed using resources from Biorender.com.
Fig. 3
Fig. 3. Role of oral microbiota in neuropsychiatric disorders.
The oral microbiota consists viruses, bacteria, archaea, fungi, and protozoa. In comparison to a healthy microbiome (eubiosis), patients with periodontitis exhibit an imbalanced microbiome (dysbiosis), which can contribute to the development of neuropsychiatric disorders. Studies utilizing postmortem brain samples have demonstrated the presence of the oral microbiota in the brains from patients with Alzheimer’s disease (AD) or Parkinson’s disease [105]. Part of the figure was designed using resources from Biorender.com.
Fig. 4
Fig. 4. Nasal microbiota in the olfactory function.
The nasal cavity can be divided into distinct regions, including the nasal vestibules, respiratory region, olfactory region, and nasopharyngeal region. The nasal microbiota colonizes these regions, and plays a crucial role in maintaining the health of the nasal mucosa and overall immune system function. There are three pathways from the mucus layer to the olfactory bulb: (a) the transcellular pathway, which involves passage through epithelial cells; (b) the paracellular pathway, which occurs between epithelial cells; and (c) the intracellular pathway, which occurs through the olfactory nerve. Considering the crucial role of the nasal microbiota within the nasal cavity, it is plausible that both the nasal microbiota and their metabolites may have a role in neuropsychiatric disorders. Part of the figure was designed using resources from Biorender.com.
Fig. 5
Fig. 5. Potential role of vaginal microbiota in the development of neuropsychiatric disorders in offspring following maternal immune activation.
The vaginal microbiota, particularly, the Lactobacillus species, plays several significant roles in maintaining vaginal health. There is an association between the composition of the vaginal microbiota and reproductive health, including the risk for spontaneous preterm birth. Maternal immune activation (MIA), which can result from a range of factors such as infections, immune challenges, stress, environmental exposures, has been linked with an increased risk of neuropsychiatric disorders in offspring. Dysbiosis of the vaginal microbiota due to MIA, along with subsequent disrupted immune responses, may foster the development of neuropsychiatric disorders in offspring. This imbalance in the vaginal microbiota might impact the synthesis of D- and L-lactic acid and other metabolites, leading to changes in pH and the immune system in the vagina. Furthermore, an imbalance in the vaginal microbiota may influence mental health issues in women throughout their lives. Part of the figure was designed using resources from Biorender.com.

References

    1. GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psych. 2022;9:137–50. doi: 10.1016/S2215-0366(21)00395-3.. - DOI - PMC - PubMed
    1. COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398:1700–12. doi: 10.1016/S0140-6736(21)02143-7.. - DOI - PMC - PubMed
    1. Yuan K, Zheng YB, Wang YJ, Sun YK, Gong YM, Huang YT, et al. A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action. Mol Psych. 2022;27:3214–22. doi: 10.1038/s41380-022-01638-z.. - DOI - PMC - PubMed
    1. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendation. Nat Rev Microbiol. 2023;21:133–46. doi: 10.1038/s41579-022-00846-2.. - DOI - PMC - PubMed
    1. Al-Hakeim HK, Al-Rubaye HT, Al-Hadrawi DS, Almulla AF, Maes M. Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study. Mol Psych. 2023;28:564–78. doi: 10.1038/s41380-022-01836-9.. - DOI - PMC - PubMed